Welcome to the ValueWiki REGENERX BIOPHARM IN (RGN) article! Register for free or click the "edit" link to contribute!

REGENERX BIOPHARM IN (RGN)

This summary section needs content! Click Here to begin writing.

Have a question about REGENERX BIOPHARM IN? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

11/28/08 5:11 am	RegeneRx: A Beaten Down Biotech (at Seeking Alpha)
11/18/08 7:11 am	[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: RGN, IXS, DLKM, VCRT, GTLT (PR Newswire)
11/17/08 8:11 am	RegeneRxs Experimental Drug Promotes Healing in Patients With Non-Healing Corneal Ulcers (Business Wire)
11/13/08 6:11 am	REGENERX BIOPHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
11/04/08 9:11 am	RegeneRx President and CEO to Speak at Rodman & Renshaw Annual Global Investment Conference (Business Wire)
10/30/08 8:10 am	REGENERX BIOPHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)
10/24/08 8:10 am	RegeneRx Sponsors "Walk a Mile in My Shoes" for National Epidermolysis Bullosa Awareness Week (Business Wire)
10/22/08 9:10 am	RegeneRx President and CEO to Speak at 7th Annual BIO Investor Forum (Business Wire)
10/01/08 8:10 am	RegeneRx to Develop RGN-457 for Cystic Fibrosis (Business Wire)
09/22/08 11:09 am	RegeneRx Enrolls First Subject in RGN-352 Phase IB Clinical Trial (Business Wire)